Latest Vaccination Stories

A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases. Dengue fever, prevalent in many tropical and subtropical...

Connie K. Ho for redOrbit.com – Your Universe Online A new study funded by the California-based health consortium Kaiser Permanente found that almost half of children under the age of two obtain vaccinations later than recommended, providing further evidence of what some health officials describe as a rise in the "undervaccination" of children. The findings were recently featured in the Journal of the American Medical Association (JAMA) Pediatrics. Using information from the...

SEATTLE, Jan. 22, 2013 /PRNewswire/ -- TapImmune Inc. (OTCBB: TPIV) is pleased to announce the January publication of a paper titled "Enzymatic Discovery of a HER-2/neu Epitope That Generates Cross-Reactive T-cells", authored by Henle et al, J.Immunol. (2013), 190, 479-488. This work, performed in the laboratory of Dr Keith Knutson at Mayo Clinic, describes the discovery of a novel HER-2/neu Class I epitope (p373-382) TapImmune has licensed from Mayo Clinic for the development of...

Lee Rannals for redOrbit.com – Your Universe Online A new flu vaccine won regulatory approval on Wednesday and its limited supplies are expected to be available this winter. Protein Sciences won the approval for Flublok, which is made with a process that does not require the virus to be grown in chicken eggs. “This approval represents a technological advance in the manufacturing of an influenza vaccine,” Dr. Karen Midthun, a senior official at the U.S. Food and Drug...

- Continuing discussion towards further cooperation - QUEBEC CITY, Jan. 17, 2013 /PRNewswire/ -  Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the execution of $15,000,000 loan agreement with a major Pharmaceutical company.  The principal of the loan is repayable on January 14, 2014 but can...

MERIDEN, Conn., Jan. 16, 2013 /PRNewswire/ -- The U.S. FDA approved Flublok for people 18-49 years old - making it the first recombinant vaccine for influenza available on the market. Approval for all people 18 years and above is expected later in 2013. Flublok features: First influenza vaccine made without the use of live influenza virus First egg-free influenza vaccine Highly purified without preservatives (thimerosal), antibiotics or adjuvants Three times the active...

Brett Smith for redOrbit.com – Your Universe Online Skeptical parents and organizations have been raising concerns about the federally recommended immunization schedule for young children in recent years over the notion that it is potentially dangerous or has negative side effects. In light of this debate, the Institute of Medicine, which advises the government, has released a new study by 14 committee members that says the benefits of the federally recommended schedule far outweigh...

Flu in epidemic proportions over parts of the U.S., PF Patients, others with Chronic Lung Disease at 2.5 times higher risk of hospitalization due to flu CULVER CITY, Calif., Jan. 16, 2013 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today it is joining forces with the Centers for Disease Control (CDC) in spreading the word to Pulmonary Fibrosis (PF) patients, families and caregivers about the need for immunizations, most urgently, the flu shot....

University of Liverpool Mass poultry vaccination programs introduced to combat Salmonella infections have led to a dramatic fall in the number of cases since the late 1990s, according to a researcher at the University of Liverpool. Salmonella are important food-borne pathogens worldwide, causing diarrhea, vomiting, nausea, fever and abdominal pain. There are currently around 6 million cases of illness from Salmonella across the EU each year, the majority of which are linked to food...

Connie K. Ho for redOrbit.com – Your Universe Online Scientists from the University of Texas-Austin (UTA) recently revealed that they have been able to develop 61 new strains of genetically engineered bacteria that could boost the effectiveness of vaccines for diseases such as cholera, HPV, the flu, and pertussis. The findings on these strains of E. coli were featured in a recent edition of the Proceedings of the National Academy of Sciences. These strains of E. coli are part of a new...